15th Annual International Congress on Hematologic Malignancies: Focus on Leukemias, Lymphomas, and Myeloma

Last Modified: September 27, 2010

Share article

Conference Dates: February 17-20, 2011
Conference Location: The Fairmont Château Whistler, 4599 Château Blvd., Whistler, British Columbia, Canada V0N 1B4

Sponsoring Group: Physicians' Education Resource

Conference Web Page URL: www.cancerlearning.com/index.cfm/fuseaction/conference.showOverview/id/5/conference_id/592

Topics Covered: Hematologic malignancies, leukemia, lymphoma, myeloma, international, treatment, monitoring, new drug approvals and indications, clinical trials

Who Should Attend: Medical oncologists, hematologists, and other health care professionals

Conference Fees: $495

Continuing Education: Yes

Also, double unrelated cord blood transplant tied to better outcomes in leukemia patients

Dec 8, 2010 - Individuals who donate peripheral blood stem cells or bone marrow do not appear to be at an overall increased risk of cancer, according to research being presented at the annual meeting of the American Society of Hematology, held from Dec. 4 to 7 in Orlando, Fla. According to another study, acute myeloid or lymphoblastic leukemia patients who receive double unrelated cord blood transplants may experience better overall outcomes than those who receive single cord blood transplants. Other studies being presented address stem cell transplant procedures in treating various hematologic malignancies and highlight zoledronic acid's ability to improve survival in multiple myeloma patients.

I Wish You Knew

How cancer patients have changed my life

View More

Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.

OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More